Much debate has focused on the possibility that the Ab response to SARS-CoV-2 may be short-lived, while T cell recognition may be strong, durable, and more common. Mild or asymptomatic infections are very common but are not usually diagnosed, making an assessment of the durability of immunity in this common group challenging. A study was done on an exposed health …
Administering bamlanivimab (formerly LY-CoV555), a monoclonal antibody for COVID-19, along with remdesivir (Veklury) was ineffective for patients hospitalized with COVID-19, a randomized trial found. In a preliminary report of the first TICO trial, hospitalized patients with COVID-19 who received a single infusion of the neutralizing monoclonal antibody LY-CoV555 at a dose of 7000 mg, did not have better clinical outcomes …
Since the first cases of COVID-19 were identified in the United States, we have learned a lot however as with anything else in life, we never stop learning! Many residents in our care contracted the COVID-19 virus and required hospitalization. Some of these residents developed blood clots in the lungs, negatively impacting their recovery. Anticoagulation therapy has become common practice …
To mitigate the spread of the 2019 novel coronavirus (SARS-CoV-2), nursing homes are following the Centers for Medicare and Medicaid Services guidelines and are not allowing communal dining, group activities, and only essential visitors are allowed. A study was conducted on data analysis of nursing home resident weights from a single 240-bed non-profit nursing home located in a suburban area, …
Vaccination against COVID-19 is critical for public safety and especially the safety of the most vulnerable among us. People living with multiple sclerosis (MS) are seeking peace of mind from the safety and effectiveness of the COVID-19 vaccines. In response, the National Multiple Sclerosis Society convened a group of expert researchers and medical professionals to review the available science and …
Trends in community infections from the novel coronavirus appear to run on par with cases among nursing home staff and residents per a recent report from the Centers for Disease Control and Prevention (CDC). This finding underscores the need to monitor local virus spread and prevent exposure to facilities, especially among staff potentially infected by family and others, and isolating …
World Health Organization (WHO) We are all being exposed to a huge amount of COVID-19 information on a daily basis and not all of it is reliable. Due to COVID-19, most of us have a new word in our vocabulary: epidemiology. It is the branch of medical science that deals with the way diseases are transmitted and can be controlled …
After several people had apparent allergic reactions at one California clinic, state health officials on Sunday told providers across the state to pause administering doses from one COVID-19 vaccine lot that arrived from Moderna. The move, made “out of an extreme abundance of caution” means that 330,000 doses distributed to 287 providers across the state can’t be used amid an …
Older adults may manifest acute illness with atypical signs and symptoms, including those that are non-localizing; however, most nursing-home residents with acute infection will also exhibit some localizing signs and symptoms of infection. Non-infectious explanations for non-localizing signs or symptoms of changes in condition should be ruled out first. Some of these changes may include: Changes in medication, Acute or …
Employment-related exposure to severe acute respiratory syndrome coronavirus (SARS-CoV-2) can endanger not only workers but also their household members. Using pre-pandemic data, the prevalence of Centers for Disease Control Prevention (CDC) risk factors for severe coronavirus disease 2019 (COVID-19) were examined. The researchers then estimated how many adults at increased risk of severe COVID-19 held essential jobs and could not …
